Mayur Ian Somaiya

Mayur Ian Somaiya

50 year
Finance
Health Technology
Consumer Services

Profile

Mayur Ian Somaiya is currently the Chief Financial Officer at NewAmsterdam Pharma Co. NV since 2023.
He previously held managing director and senior research analyst positions at Piper Sandler & Co. (Broker) from 2010 to 2013, managing director positions at Thomas Weisel Partners LLC from 2003 to 2009, managing director and senior analyst positions at Nomura Securities International, Inc. from 2013 to 2016, managing director and analyst positions at BMO Capital Markets Corp.
(Broker) from 2016 to 2018, and was the Chief Financial Officer at TCR2 Therapeutics, Inc. from 2018 to 2021.
He also worked as an analyst at Prudential Securities from 1997 to 1999 and as a senior analyst at Morgan Stanley & Co. LLC from 2000 to 2002.
Additionally, he worked as a consultant at Carson Group, Inc. (New York) in 1996.
Mr. Somaiya received his undergraduate degree from New York University in 1995.

Mayur Ian Somaiya active positions

Former positions of Mayur Ian Somaiya

CompaniesPositionEnd
TCR2 THERAPEUTICS INC. Director of Finance/CFO 2021-12-09
Analyst-Equity 2018-03-31
Analyst-Equity 2015-12-31
Analyst-Equity 2013-10-30
Analyst-Equity 2009-10-14
See the detail of Mayur Ian Somaiya's experience

Training of Mayur Ian Somaiya

New York University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mayur Ian Somaiya's experience

Connections

100 +

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
FRAZIER LIFESCIENCES ACQUISITION CORPORATION

Health Technology

Private companies8
Prudential Securities

Finance

Finance

Finance

Finance

Finance

Finance

Finance

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Mayur Ian Somaiya